25911 - 妊妊妊妊妊妊妊妊妊妊 Simon Weitzman,...

Info iconThis preview shows pages 1–10. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: 妊妊妊妊妊妊妊妊妊妊 Simon Weitzman, MD,MPH 妊妊妊妊妊妊 妊妊妊妊妊妊妊妊妊妊妊妊 • 妊妊妊妊妊妊妊 • 妊妊妊妊 • 妊妊妊妊妊妊妊 妊妊妊妊妊妊妊妊妊妊妊妊 • 妊妊妊妊妊妊妊 • 妊妊妊妊 • 妊妊妊妊妊妊妊 妊妊妊妊妊妊妊妊妊妊 • 1 妊妊妊妊妊妊妊妊妊妊 GCT 妊 • 妊妊妊妊妊妊妊妊 OGTT 妊 妊妊妊妊妊妊妊 WHO 妊 妊妊妊妊妊妊妊妊妊 NDDG 妊 Coustan 妊妊妊妊 妊妊妊妊妊妊妊妊 妊妊 妊妊妊妊 (mg/dL) 妊妊妊妊 1 妊妊 2 妊妊 3 妊妊 WHO 妊 7 5g 妊 140 200 NDDG (100g) 105 195 165 145 Coustan (100g) 95 180 155 140 妊妊妊妊妊妊妊妊妊妊妊妊 • 妊妊妊妊妊妊妊 • 妊妊妊妊 • 妊妊妊妊妊妊妊 妊妊妊妊妊妊妊妊妊妊 • 妊妊 妊妊妊 妊妊妊 50g 妊妊妊妊妊妊妊妊 >=186mgdL 妊 • 妊妊妊 38.2% • 妊妊妊 93.3% • 妊妊妊妊妊 78.6% • 妊妊妊妊妊 70.0% 50g 妊妊妊妊妊妊妊妊...
View Full Document

This note was uploaded on 03/08/2012 for the course PHARM 300 taught by Professor Staff during the Fall '11 term at Rutgers.

Page1 / 23

25911 - 妊妊妊妊妊妊妊妊妊妊 Simon Weitzman,...

This preview shows document pages 1 - 10. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online